carbostyril has been researched along with Ventricular Dysfunction, Left in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (50.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 1 (50.00) | 2.80 |
Authors | Studies |
---|---|
Cheng, C; Cheng, J; Hao, P; Sui, W; Wang, X; Xing, Y; Xue, F; Zhang, C; Zhang, J; Zhang, M; Zhang, Y | 1 |
Bartels, GL; Krauss, XH; Kruijssen, HA; Remme, WJ; Storm, CJ; van der Ent, M; van Hoogenhuyze, DC; van Schelven, D | 1 |
1 trial(s) available for carbostyril and Ventricular Dysfunction, Left
Article | Year |
---|---|
Acute hemodynamic effects and preload-dependent cardiovascular profile of the partial phosphodiesterase inhibitor nanterinone in patients with mild to moderate heart failure.
Topics: Aged; Angiotensin-Converting Enzyme Inhibitors; Blood Pressure; Cross-Over Studies; Diuretics; Enalapril; Female; Heart Failure; Hemodynamics; Humans; Imidazoles; Male; Middle Aged; Phosphodiesterase Inhibitors; Pulmonary Wedge Pressure; Quinolones; Single-Blind Method; Vascular Resistance; Ventricular Dysfunction, Left | 1996 |
1 other study(ies) available for carbostyril and Ventricular Dysfunction, Left
Article | Year |
---|---|
Angiotensin IV attenuates diabetic cardiomyopathy
Topics: Angiotensin II; Animals; Apoptosis; Autophagy; Blood Glucose; Cell Line; Diabetes Mellitus, Experimental; Diabetic Cardiomyopathies; Disease Models, Animal; Fibrosis; Forkhead Box Protein O1; Glucose; Male; Mice; Mice, Inbred C57BL; Myocytes, Cardiac; Oxidative Stress; Quinolones; Signal Transduction; Streptozocin; Ventricular Dysfunction, Left | 2021 |